Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
VRN-07 by ORIC Pharmaceuticals for Solid Tumor: Likelihood of Approval
VRN-07 is under clinical development by ORIC Pharmaceuticals and currently in Phase II for Solid Tumor. According to GlobalData, Phase...
VRN-07 by ORIC Pharmaceuticals for Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer): Likelihood of Approval
VRN-07 is under clinical development by ORIC Pharmaceuticals and currently in Phase II for Human Epidermal Growth Factor Receptor 2...
VRN-07 by ORIC Pharmaceuticals for Non-Small Cell Lung Cancer: Likelihood of Approval
VRN-07 is under clinical development by ORIC Pharmaceuticals and currently in Phase II for Non-Small Cell Lung Cancer. According to...